Skip to main content
FinSpry Logo
FinSpry
SHPH logo
SHPH
(NASDAQ)
Shuttle Pharmaceuticals Holdings, Inc.
$4.02-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Shuttle Pharmaceuticals Holdings (SHPH) Company Profile

Complete business overview, executive team, trading details, and corporate information.

Shuttle Pharmaceuticals Holdings, Inc.
SHPH•Nasdaq Stock Market•Healthcare•Drug Manufacturers - Specialty & Generic

About Shuttle Pharmaceuticals Holdings

Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to treat cancers. It owns a pharmaceutical software artificial intelligence (AI) driven platform for molecular discovery and early-stage drug development. The company was founded in 2012 and is headquartered in Gaithersburg, Maryland.

Stock Details

ExchangeNasdaq Stock Market (NASDAQ)
CurrencyUSD - USD
TypeStock

Contact Information

Websitewww.shuttlepharma.com
Phone240 403 4212
Address
401 Professional Drive, Suite 260 Gaithersburg, Maryland 20879 United States

Corporate Identifiers

CIK0001757499
CUSIP825693500
ISINUS8256935003
SIC2834

Leadership Team & Key Executives

Christopher Robert Cooper BBA, M.B.A.
Interim Chief Executive Officer and Director
Dr. Milton Brown CSC, M.D., Ph.D.
Co-Founder
Dr. Mira Jung Ph.D.
Co-Founder and Chief Scientific Officer for Biology
Yuying Liang B.A., CPA
Chief Financial Officer
Dr. Tyvin A. Rich M.D.
Chief Clinical Officer and Chief Medical Officer
Michael P. Vander Hoek
Vice President for Operations and Regulatory